Answers are grounded in this paper and cite their sources.
We report the case of a 16-year-old girl with acute myelogenous leukemia with disseminated fusariosis, who responded to salvage posaconazole therapy. She subsequently received additional cytotoxic chemotherapy and allogeneic hematopoietic stem cell transplantation with posaconazole continued as secondary prophylaxis. Despite intensive immunosuppressive therapy for graft-versus-host disease, no recrudescence of infection occurred.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: